Aventis implements SciQuest's Enterprise Substance Manager to establish common logistics infrastructure for research facilities
Advertisement
SciQuest, Inc. announced the successful global implementation of Enterprise Substance Manager(TM) (ESM), a fully scalable, enterprise-wide software solution for new drug discovery, compound management, requisitioning and fulfillment processes at R&D sites for Aventis.
Aventis has successfully implemented the tool at its research facilities in Bridgewater, NJ; Tucson, Ariz.; Vitry/Romainville, France and Frankfurt, Germany. The implementation enables the global management of proprietary research compounds while establishing a common logistics infrastructure and processes across all research sites.
SciQuest Enterprise Substance Manager(TM) is a software solution used by research scientists and compound management personnel to manage inventories of proprietary compounds and sample plates that are used in high-throughput screening, genomics and combinatorial chemistry operations. ESM provides real-time access to compound data on a local or global basis, maximizes the potential of expensive and highly sophisticated robotic equipment and ensures that drug candidates are tracked and accounted for as they pass through the drug discovery process.
"Researchers and the unique materials they synthesize, screen and test are two of the most valued assets of a pharmaceutical organization," said Stephen J. Wiehe, president and CEO of SciQuest. "Enterprise Substance Manager will help Aventis maximize researcher productivity while effectively leveraging their growing libraries of promising compounds in their research facilities around the world."
Most read news
Other news from the department research and development
These products might interest you

OMNIS-Software by Metrohm
Efficient Lab Workflows Through Intelligent Data Management
Central Data Management with an Intuitive User Interface for the Highest Compliance Standards

Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management

LAUDA.LIVE by LAUDA
LAUDA.LIVE - The digital platform for your device management
Comprehensive fleet management options for every LAUDA device - with and without IoT connectivity

ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Clean energy 'bio batteries' a step closer
Singapore researchers first to transform carbon dioxide into methanol - 'Green' method for sequestration and conversion of greenhouse gas
Nanotechnology leads to stronger cleanroom standards - Cleanzone 2015: Cleanroom compatibility of all types of equipment
Andor Technology plc acquires Bitplane AG
BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol - 50-50 joint venture company building first commercial project in Highlands County, Florida
Zeon announce a general price increase in Europe for all Nitrile Rubber
Two BGU Researchers Awarded prestigious ERC Starting Grants
Myriad Genetics and Syngenta Complete Rice Genome Map

Neutron holography technique for obtaining clear 3-D atomic images
OMV and IPIC: Bundling of chemical activities in Borealis subsidiary completed - OMV and IPIC complete the incorporation of shares of AMI Agrolinz Melamine (each held 50% of AMI) into their joint subsidiary Borealis
Myriad Genetics Discovers High Cholesterol Gene
